Wednesday, 7 October 2026 Every NSE & BSE announcement, by company
ALFA Filings Every announcement, straight from the exchange

Invicta Diagnostic Ltd

NSE: INVICTA · Healthcare · 36 announcements

Share price
₹66.50
Market cap
₹83.60 Cr
Revenue (annual)
₹32.35 Cr
Net profit (annual)
₹4.91 Cr
P/E (TTM)
17.0×Sector 53.1×
Promoter holding
66.70%
FII holding
4.20%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

22:19 IST NSE
Management Change

Invicta Diagnostic Management Change

Invicta Diagnostic Limited reported changes to its leadership and audit team, including a director's re-appointment, a designation change, and a new secretarial auditor.

18:55 IST NSE
Management Change

Invicta Diagnostic Management Change

Invicta Diagnostic Limited announced the resignations of Executive Director Rohit Prakash Srivastava and Manager Konica Rohit Srivastava. Additionally, Director Sanket Vinod Jain was redesignated as Executive Director.

21:03 IST NSE
Management Change

Invicta Diagnostic Management Change

Invicta Diagnostic Limited reported a management change in its subsidiary, Porteus Pathogenius LLP, involving the appointment of Mayur Shivdas Kasat following Vishwajeet Arvind Burungale's stake sale.

20:41 IST NSE
Management Change

Invicta Diagnostic Management Change

Invicta Diagnostic Limited appointed M/s. Shrenik Nagaonkar and Associates as Secretarial Auditor for five years. The firm brings 19 years of governance and capital markets expertise.

Execution
60 months
21:10 IST NSE
Management Change

Invicta Diagnostic Management Change

Invicta Diagnostic Limited has redesignated Rohit Prakash Srivastava as Whole Time Director Finance for a 5-year term, effective April 17, 2026. Srivastava brings over 19 years of experience across healthcare and finance. This appointment formalizes his executive leadership role within the company's senior management team.

Execution
5